Company Filing History:
Years Active: 2022
Title: Carolin Thiele: Innovator in Nucleic Acid Delivery Systems
Introduction
Carolin Thiele is a prominent inventor based in Tübingen, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of innovative delivery systems for nucleic acids. Her work focuses on enhancing the efficiency and effectiveness of nucleic acid therapies.
Latest Patents
Carolin Thiele holds a patent for "Hybrid carriers for nucleic acid cargo." This invention provides a composition for the delivery of a nucleic acid compound, which includes a cationic peptide or polymer and a lipidoid compound. The nucleic acid compound can be any chemically modified or unmodified DNA or RNA. The formulation emphasizes a low amount of lipidoid relative to the cationic peptide or polymer, optimizing the delivery process.
Career Highlights
Carolin is currently associated with CureVac AG, a leading company in the field of mRNA technology. Her role at CureVac AG allows her to work on cutting-edge research and development projects that aim to revolutionize therapeutic approaches using nucleic acids.
Collaborations
Some of her notable coworkers include Patrick Baumhof and Joanna Rejman. Their collaborative efforts contribute to the advancement of innovative solutions in the biotechnology sector.
Conclusion
Carolin Thiele's work in nucleic acid delivery systems exemplifies the potential of biotechnology to transform medical treatments. Her patent and contributions at CureVac AG highlight her role as a key innovator in this vital field.